The Native Antigen Company
The Native Antigen Company specializes in the development and manufacture of high-quality viral and bacterial antigens, antibodies, and kits for diagnostic and research applications. Their expertise supports the global scientific community in infectious disease research and vaccine development.Content by The Native Antigen Company
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
Antigen designed to support immunoassay and vaccine development applications
| 1 min read
Addition of six new reagents, including four which are unique to the market
| 2 min read
This kit can be used to identify and qualitatively assess the ability of antibodies to neutralize SARS-CoV-2-receptor binding
| 1 min read
Antigens and antibodies for livestock and companion animal diseases to support development of diagnostics and vaccines
| 1 min read
These 10 antibodies recognize different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-specific and do not cross-react with other human coronaviruses
| 2 min read
OXGENE and The Native Antigen Company are developing an improved, scalable approach to SARS-CoV-2 antigen manufacture
| 2 min read
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development
| 2 min read
Highly scalable kits enable researchers to prepare liquid-stable antigen and antibody conjugates with a wide range of labels including enzymes, fluorochromes, and biotin
| 2 min read
Recombinant expression of Rubella VLPs offers a reliable source of reagents for consistency in immunoassay development and manufacturing
| 2 min read
Page 1 of 1 - 9 Total Items
